Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake
- PMID: 7759783
- DOI: 10.1007/BF03349695
Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake
Abstract
A high incidence of toxic nodular goiter has recently been described in areas of relatively low iodine intake. We studied the development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake (median 87 micrograms/h). The material comprised a total of 557 patients admitted to our department in the period 1978-88. The follow-up material consisted of 214 patients with a median age of 55 yr (19-86). Eighty-eight percent were females. The period of observation was 33 months (1-205). All patients had technetium thyroid scans, serum T3, serum T4, T3 uptake test and serum TSH performed. TRH tests were performed in 58 patients. During the follow-up period 45 initially euthyroid patients became hyperthyroid (18%). The incidence increased with age, and the median age in the group, who developed hyperthyroidism, was 65 yr. An estimated minimal incidence of toxic nodular goiter was 23/100,000/yr. Contrary to previous assumption, hyperthyroidism developed frequently in elderly patients with nodular goiter in a low iodine intake area. Thyroid cancer was found in 13 patients corresponding an estimated incidence of 1.5/100,000/yr. The cancer incidence was very low compared to other nordic countries with high iodine intake. This finding may suggest a possible influence of iodine intake on the incidence of thyroid cancer.
Similar articles
-
The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.Thyroid. 2008 Jun;18(6):641-5. doi: 10.1089/thy.2007.0348. Thyroid. 2008. PMID: 18578614
-
Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.Clin Endocrinol (Oxf). 1993 Jul;39(1):67-71. doi: 10.1111/j.1365-2265.1993.tb01752.x. Clin Endocrinol (Oxf). 1993. PMID: 8348708
-
Transient thyrotoxicosis in endemic goitre patients following exposure to a normal iodine intake.Clin Endocrinol (Oxf). 1984 Dec;21(6):631-7. doi: 10.1111/j.1365-2265.1984.tb01405.x. Clin Endocrinol (Oxf). 1984. PMID: 6439440
-
TSH secretion and regulation in endemic goiter and endemic cretinism.Prog Clin Biol Res. 1983;116:119-30. Prog Clin Biol Res. 1983. PMID: 6304776 Review.
-
Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter.J Endocrinol. 2014 Nov;223(2):T97-114. doi: 10.1530/JOE-14-0461. J Endocrinol. 2014. PMID: 25297557 Review.
Cited by
-
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.J Endocrinol Invest. 2014 Dec;37(12):1181-6. doi: 10.1007/s40618-014-0128-z. Epub 2014 Jul 10. J Endocrinol Invest. 2014. PMID: 25008459
-
Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).J Endocrinol Invest. 2009 Feb;32(2):184-91. doi: 10.1007/BF03345711. J Endocrinol Invest. 2009. PMID: 19411820 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical